ASM History

2024 Annual Scientific Meeting

Partners
Program
Speakers

Principal Conference Partner

Diamond Partner, Exhibitor

Gold Partner, Exhibitor

Gold Partner

Silver Partner, Exhibitor

International Speaker Partner

Program Partner

Grant Partner

Destination Partner

Conference App Partner

Exhibitor

Pre-ASM 31/07/2024
Thurs 01/08/2024
Fri 02/08/2024
Sat 03/08/2024

Time	Balcony Room 1 & 2	Balcony Room 3 & 4	Meeting Room B - Level 2	Offsite - Robinson Research Institute	Offsite - Women’s and Children’s Hospital
0900-1700	Pre-conference Workshop ANZCHOG Pre-Conference Nurses Workshop Made by possible by MY ROOM View workshop program	Pre-conference Workshop ANZCHOG Pre-Conference Education Day: Holistic Patient and Family Care from Diagnosis to Survivorship Made possible by MY ROOM View workshop program	Pre-conference Half Day Workshop Alexion Afternoon Workshop Neurofibromatosis Type 1 (NF1) Masterclass Brought to you by Alexion View workshop information	Pre-conference Workshop ANZCHOG Paediatric Oncology Fellows Day Made possible by Day One Biopharmaceuticals View workshop program	Pre-conference Workshop ANZCHOG Pre-Conference Clinical Research Professionals Workshop (Closed meeting) Made possible by Minderoo View workshop information


Time	Grand Ballroom
0730-0900	Arrival tea and coffee and registration open
0900-0930	Opening Ceremony
0930-1015	Plenary 1 – Psychosocial Chairs: Prof Jordan Hansford & Dr Sarah Hunter Neurocognitive Sparing with Proton Radiotherapy in Pediatric Neuro-Oncology Prof Lisa Kahalley, Baylor College of Medicine/Texas Children’s Hospital
1015-1100	Plenary 2 – Global Health Chairs: Prof Jordan Hansford & Dr Sarah Hunter Paediatric neuro-oncology in LMIC: making the impossible possible Prof Eric Bouffet, The Hospital For Sick Children Involvement made possible by Robert Connor Dawes Foundation
1100-1130	Morning Tea – Trade Display and Poster Viewing
1130-1215	Plenary 3 – Leukaemia/Lymphoma Chairs: Prof Deb White & Dr Toby Trahair Shifting the dial for infants with acute lymphoblastic leukaemia A/Prof Rishi Kotecha, Perth Children’s Hospital
1215-1300	Plenary 4 – Solid Tumors Chairs: Prof Deb White & Dr Toby Trahair Personalized medicine approaches for high-risk and relapsed neuroblastoma Prof Angelika Eggert, Charite University Medicine Involvement made possible by Recordati
1300-1415	Lunch – Trade Display and Poster Viewing

	Balcony Room 1 – 3
	1315-1400 Jazz Pharmaceuticals Partner Lunch Symposium Dr Luke Maese,Univeristy of Utah, Huntsman Cancer Institute, Primary Children’s Hospital
	Involvement made possible by Jazz Pharmaceuticals
1415-1545	ANZCHOG Clinical Trials Update Chair: Dr Maria Kirby
1545-1615	Afternoon Tea – Trade Display and Poster Viewing
1615-1745	Ballroom A	Ballroom B	Ballroom C
	Concurrent 1 – Precision medicine Chairs: Dr Marion Mateos & Dr Noemi Fuentes-Bolanos	Concurrent 2 – CNS/Radiotherapy Chairs: Dr Neevika Manoharan & Dr Raelene Enderby	Concurrent 3 – Infection/Supportive Care Chairs: Mr Josh Britcher & Ms Rachel Edwards
	An old dog with new tricks- updates on treatment for LCH A/Prof Adam Nelson, Sydney Children’s Hospital Involvement made possible by Linkhealth Care	Managing recurrent medulloblastoma in infants and young children Prof Eric Bouffet, The Hospital For Sick Children Involvement made possible by Robert Connor Dawes Foundation	There is no place like home: results of the national low-risk FN implementation study A/Prof Gabrielle Haeusler, Royal Children’s Hospital
	Factors influencing uptake of individualised precision medicine treatment recommendations for high-risk paediatric oncology patients: Results from the PRISM Engagement with Clinicians (PRE-CLIN) study Dr Akanksha Senapati, Hospital For Sick Children	A novel cancer associated protein of the ECM may contribute to immunosuppression of the tumour immune microenvironment of diffuse midline glioma Mr Bryce Thomas, University Of Newcastle	Assessing COVID-19 antibody response in children with cancer following immunisation and infection Dr Daniel Yeoh, Perth Children’s Hospital
	Precision Medicine in Paediatric Oncology: Lessons Learned and the Evolution of ZERO2 Ms Meera Warby, Sydney Children’s Hospital	Preliminary Insights and Development of the Australian Particle Therapy Clinical Quality Registry – ASPIRE Ms Kelly Skelton, Australian Bragg Centre For Proton Therapy And Research	Multidisciplinary engagement is essential to improve physical activity participation in the acute paediatric cancer setting: The Paediatric Oncology Physical Activity Promotion (POPP) Framework Dr Sarah Grimshaw, Murdoch Children’s Research Institute
	Parents’ experiences of treatment recommendations from a precision medicine trial for poor prognosis childhood cancer: Findings from PRISM-Impact Dr Kate Hetherington, University Of New South Wales	Reversing the cold tumour immune microenvironment of diffuse midline glioma through dopamine receptor antagonism Ms Mika Persson, University Of Newcastle	Invasive fungal disease and antifungal prophylaxis in children with acute leukemia: a multicentre Australian cohort study Dr Daniel Yeoh, Perth Children’s Hospital
	Factors that determine treatment decision making in precision medicine in paediatric cancer: A systematic review of qualitative and quantitative studies Miss Kathy Xian Zou, University Of New South Wales	DNA Damage Response Inhibitors Synergise With Radiotherapy for the Treatment of Pineoblastoma and Atypical Teratoid Rhabdoid Tumour Dr Jessica Buck, Telethon Kids Institute	Bringing it; Paediatric Palliative Care Innovation in Communication Mrs Sara Fleming, Palliative Care Australia
	The Role of Pharmacogenomics in Oncofertility Risk Stratification Tools Ms Tayla Stenta, Murdoch Children’s Research Institute		Palliative care for children and adolescents with non-curative brain tumours: A scoping review Miss Marmareen Bakhtary, Melbourne Medical School
1745-1915	Welcome Reception in Exhibition Welcome Reception brought to you by Children’s Cancer Foundation


Time	Balcony Room 1 – 3
0730 – 0845	Bayer Breakfast Symposium
0730 – 0845	Paediatric Thyroid Cancer – From Orphan Cancer to National Multidisciplinary Collaborative Chair: A/Prof Antoinette Anazodo Panel: Dr Noemi Fuente-Bolanos, Dr Gideon Sandler and A/Prof Paul Benitez-Aguirre Brought to you by Bayer
0900-0945	Grand Ballroom
0900-0945	Plenary 5 – Cancer Predisposition Chairs: Dr Matt O’Connor & Prof Nick Gottardo Cancer Predisposition: Finding a Place and Bridging the Gap Dr Luke Maese,Univeristy of Utah, Huntsman Cancer Institute, Primary Children’s Hospital Involvement made possible by Jazz Pharmaceuticals
0945-1030	Plenary 6 – Cellular Therapies in Neuro-Oncology Chairs: Dr Matt O’Connor & Prof Nick Gottardo CAR T cells for Pediatric CNS Tumors: The End of the Beginning Dr Nick Vitanza, Seattle Children’s Involvement made possible by RUNDIPG
1030-1115	Morning Tea – Trade Display and Poster Session
1030-1115	ANZCHOG 2024 ASM Poster Session View poster presenter details via the conference app
1115-1245	Ballroom A	Ballroom B	Ballroom C
	Concurrent 4 – Leukaemia/Lymphoma Chairs: Dr Siobhan Cross & A/Prof Rishi Kotecha	Concurrent 5 – Solids Tumors Chairs: Dr Rebecca Manudhane & Dr Annie Ryan	Concurrent 6 – Indigenous Health Chairs: Dr Myra Ruka & Dr Louise Evans
	What are the Medal Chances in Childhood Acute Myeloid Leukaemia? A/Prof Andy Moore, Queensland Children’s Hospital	A CAR T-cell study in bone sarcoma Dr Geoff McCowage, Children’s Hospital at Westmead
	High expression of NTRK1 in ETV6::RUNX1 positive acute lymphoblastic leukaemia drives factor independence and sensitivity to the TRK inhibitor larotrectinib Dr Susan Heatley, South Australian Health And Medical Research Institute (SAHMRI)	Efficacy, Safety, and Treatment Hold Wait-and-See Outcomes of Larotrectinib in Pediatric Patients With TRK Fusion Sarcomas A/Prof Antoinette Anazodo, Kids Cancer Centre	Co-designing an Aboriginal community-led program of childhood cancer research Dr Jessica Buck, Telethon Kids Institute
	Genomic characterisation of PAX5alt B-cell acute lymphoblastic leukaemia reveals novel PAX5 fusions Dr Jacqueline Rehn, South Australian Health And Medical Research Institute (SAHMRI)	Patterns of relapse and outcomes for children with relapsed/refractory High-Risk Neuroblastoma in Australia and New Zealand Dr Bhavna Padhye, The Children’s Hospital at Westmead	Towards precision cancer medicine for Aboriginal health equity Dr Justine Clarke, Telethon Kids Institute
	Asparaginase use in 2024 – from TDM to Guidelines Dr Matt O’Connor, Women’s and Children’s Hospital Involvement made possible by Servier	Exploring Models of Care and the Advanced Practice Nurse role in cancer genetics Mr Andrew Grant, Sydney Children’s Hospital	Implementing Indigenous Data Sovereignty for Precision Medicine A/ Prof Jimmy Breen, Telethon Kids Institute & Australian National University
		Using muscle magnetic resonance imaging to predict physical outcomes in childhood musculoskeletal sarcoma: An observational study Mrs Claire Laurie, Royal Children’s Hospital, University Of Melbourne	Te Mana o te Awa Ellyn Proffit, Te Whatu Ora Waikato
1245-1400	Lunch – Trade Display and Poster Viewing
	Balcony Room 1 – 3
	1300-1345 Alexion Lunch Symposium
	To be or not to BMT, The Changing treatment paradigm of lysosomal acid lipase deficiency (LAL-D) with ERT Prof Peter Shaw Prof Maria Fuller A/Prof Kaustuv Bhattacharya Brought to you by Alexion
1400-1530	Ballroom A	Ballroom B	Ballroom C
	Concurrent 7 – Cellular Therapies in Solid Tumours Chairs: A/Prof Andy Moore & Dr Geoff McCowage	Concurrent 8 – Non-malignant Haematology Chairs: Dr Manika Pal & Anne Jackson	Concurrent 9 – Allied Health/ Supportive/Oncofertility Chairs: Ms Kate Turpin & A/Prof Antoinette Anazodo
	Australian experience of GD2-specific CAR-T therapy for children with diffuse intrinsic pontine glioma Dr Tessa Gargett, Royal Adelaide Hospital	An overview of the uncommonly common bone marrow failure syndromes A/Prof Adam Nelson, Sydney Children’s Hospital Involvement made possible by Linkhealth Care	Ripple: Introducing Patient-Reported Quality of Life Assessment into South Australian Paediatric Oncology Practice Ms Mikaela Doig, University of South Australia
	‘Helping stem cells to travel safely so our patients don’t have to’; Gene therapy for RAG1 Deficient SCID; Challenges and learnings in opening the first Australian site for ex vivo gene therapy in children Dr Hannah Walker, The Royal Children’s Hospital	Bone Disease in SCD Dr Will Cundy, Women’s and Children’s Hospital	Oncology Nurse involvement in pathways for fertility preservation in children and adolescents undergoing treatment for cancer – what to do when there is no fertility co-ordinator? Ms Jessica Spragg, Perth Children’s Hospital
	“BANDICOOT – Building Adaptive Novel Disease and Intervention Clinical trials Optimising Overall survival after Transplant in Children” A/Prof Rachel Conyers, Murdoch Children’s Research Institute	Comprehensive care in sickle cell disease Ms Louise English, Women’s and Children’s Hospital	The Use of Goserelin in Adolescent Oncofertility Dr Joanne Liu, Western Health
	A Single Centre Experience of Peripheral Blood Stem Cell Mobilisation and Collection Practices in Paediatric Patients with Solid Tumours Dr Meg Musarra, Sydney Children’s Hospital	Pain Management in Sickle Cell Disease Dr Kirsten Ball, Women’s and Children’s Health Network	The ‘Engage’ program – a novel distance-delivered childhood cancer survivorship intervention Ms Karen Johnston, Sydney Children’s Hospital
	Information needs of parents of paediatric patients before their child’s bone marrow transplantation Miss Dyan Cana, The Royal Children’s Hospital Melbourne	Management of Haemophagocytic Lymphohistiocytosis in the Biologics Era Dr Jovanka King, Women’s and Children’s Hospital	Evaluating adherence to healthcare recommendations among childhood cancer survivors enrolled in a distance-delivered survivorship program Mrs Rachael Baldwin, Sydney Children’s Hospital
			Emerge: An e-health model of care for paediatric patients and families at the end-of treatment for acute lymphoblastic leukaemia A/Prof Maria McCarthy, Murdoch Children’s Research Institute
1530-1545	Afternoon Tea – Trade Display and Poster Viewing
1545-1615	Ballroom A	Ballroom B
	Recordati Rare Diesases Meet the Expert Session Prof Angelika Eggert, Charite University Medicine	Alexion Meet the Expert Session Prof Jordan Hansford, Women’s and Children’s Hospital Dr Geoff McCowage, Children’s Hospital at Westmead
	Involvement made possible by Recordati	Involvement made possible by Alexion
1630-1745	Grand Ballroom
	ANZCHOG 2024 ASM Best Abstracts Chairs: Ms Rachel Edwards & Prof Jordan Hansford
	Clinical Utility of Comprehensive Molecular Profiling in Childhood Brain Tumours in ZERO2 Study A/Prof Loretta Lau, Sydney Children’s Hospital
	Inclusiveness in patient-reported outcome measures (PROMs): a resource about translations and cross-cultural validations from CQUEST Dr Carrie-anne Ng, University of Technology Sydney
	Mitigating immune suppressive signatures in paediatric cancers Dr Omar Elaskalani, Telethon Kids Institute
	Impact of time to antibiotic on clinical outcome in paediatric febrile neutropenia: analysis of 1685 episodes A/Prof Gabrielle Haeusler, Royal Children’s Hospital
	Parent’s need for help and access to supportive care resources in the first 2 years after their child’s acute lymphoblastic leukaemia diagnosis Dr Joanna Fardell, UNSW, Kids Cancer Centre, Sydney Children’s Hospital, Western Sydney Youth Cancer Service
1900-0000	Gala Dinner Adelaide Town Hall


Time	Grand Ballroom
0830-0900	Arrival tea/coffee in exhibition
0900-0945	Plenary 7 – Childhood Cancer Chairs: Dr Frank Alvaro & Dr Michael Osborn Then, now and future: Lessons from life members Prof Henry Ekert AM, ANZCHOG Life Member Rethinking success: beyond 5-year survival Prof Richard Cohn AM, Sydney Children’s Hospital
0945-1015	Morning Tea – Trade Display and Poster Viewing
1015-1100	Plenary 8 – Indigenous Health Chairs: Dr Sophie Jessop & Dr Jimmy Breen Equity by design Aotearoa New Zealand Dr Myra Ruka, Hei Ahuru Mowai
1100-1145	Plenary 9 – Indigenous Health panel Chair: Dr Sophie Jessop Dr Myra Ruka, Hei Ahuru Mowai A/Prof Jimmy Breen, Telethon Kids Institute & Australian National University Dr Justine Clark, Telethon Kids Institute Dr Jessica Buck, Telethon Kids Institute
1145-1230	Closing ceremony

Prof Lisa Kahalley

Baylor College of Medicine ⋅ Texas Children's Hospital

A/Prof Jimmy Breen

Telethon Kids Institute & Australian National University

Dr Luke Maese

Univeristy of Utah, Huntsman Cancer Institute, Primary Children's Hospital

2023 Annual Scientific Meeting

Partners
Program
Speakers

Silver Partner, Exhibitor

Diamond Partner, Exhibitor

Gold Partner, Exhibitor

Gold Partner

Program Partner

Diamond Partner, Exhibitor

International Speaker Partner

International Speaker Sponsor

Program Partner

Grant Partner

Meeting App Partner

Destination Partner

Exhibitor

Pre-ASM 23/08/2023
Thurs 24/08/2023
Fri 25/08/2023
Sat 26/08/2023

Get the most out of the Annual Scientific Meeting by ANZCHOG by registering for the pre-ASM workshops. Please see below for more information on the workshops.

ANZCHOG TACTIC (Transplantation & Cellular Therapy in Children) Group Annual Meeting (closed meeting)
Wednesday 23 August 1300 – 1700 at Perth Children’s Hospital

Radiation Oncology Training Course
TUE 22 - THU 24 AUG

A three-day course featuring an invited international speaker and in-depth training on paediatric CNS tumours.

When:
Starts Tuesday 22 August

Where:

There are two locations for this course.

Day 1
Tuesday 22 August
1:00pm – 5:00pm

Department of Radiation Oncology
Sir Charles Gairdner Hospital
SCGH Cancer Care Room 1, DD Block
1 Hospital Avenue
Nedlands, Perth 6009
Western Australia

Day 2 & 3
Wednesday 23 & Thursday 24 August:
The Westin, Perth

Prof Arnold Paulino,
MD Anderson
Texas, USA

TIMETABLE - TUE 22 AUG

	TUESDAY 22nd August 2023	Location
1230	PROTC Workshop, Cancer Care Room 1 & 2, DD Block, Ground Floor Sir Charles Gairdner Hospital
1300-1315	CSI Case Study A/Prof J. Dass	CCMR1
1315-1330	CSI Planning C. Wan
1330-1345	CSI Junctions Dr M. Skorska
1345-1355	CSI Side Effects A/Prof J. Dass
1355-1400	Q&A
1400-1415	TBI Case Study A/Prof J. Dass
1415-1435	TBI Planning C. Wan
1435-1450	TBI Physics Aspects G. Neveri
1450-1455	TBI Side Effects A/Prof J. Dass
1455-1500	Q&A
1500-1515	Afternoon tea
1515-1615	Proton Therapy Prof. A. Paulino
1615-1630	Introduction to stereotactic radiotherapy using Cyberknife M6 System Dr J. Dass
1630-1640	Cyber Knife Demonstration Group 1 Dr M. Skorska
1640-1650	Cyber Knife Demonstration Group 2 Dr M. Skorska	Wandoo

TIMETABLE - WED 23 AUG

	Wednesday 23rd August 2023
	Westin Hotel
0830-0900	Registration open
0900-1030	Paediatric CNS Tumours – Part 1
0900-1000	Challenges and differences between adults and children Dr Frank Saran
1000-1030	Introduction to molecular biology of paediatric tumours Prof Nick Gottardo
1030-1100	Morning tea
1100-1200	Paediatric CNS Tumours – Part 2
1100-1130	CNS tumours – Radiotherapy (Medulloblastoma and GCT) Dr Alison Salkeld
1130-1200	Gliomas/Ependymomas/Craniopharyngiomas Dr Michelle Li
1200-1300	Lunch
1300-1430	Paediatric Solid Tumours – Part 1
1300-1330	Ewing’s Sarcoma Robyn Cheuk
1330-1400	Rhabdomyosarcoma Chris Harrington
1400-1430	Lymphoma Dr Jennifer Chard
1430-1500	Afternoon tea
1500-1700	Paediatric Solid Tumours – Part 2
1500-1530	Wilms tumours Prof Arnold Paulino
1530-1630	Neuroblastoma Dr Greg Wheeler
1630	Welcome drinks

TIMETABLE - THU 24 AUG

	Thursday 24th August 2023
	Westin Hotel
0900-0940	RT associated late toxicity Dr Greg Wheeler
0940-1020	Palliative Care Management with Radiotherapy Ben Hindson
1020-1035	Morning tea
1035-1115	Invited Speaker – MD Anderson Cancer Centre Dr Arnold Paulino
1135-1155	RANZCR Paediatric Examiner’s Quarter (Trainees only) Dr Mandy Taylor
1155-1225	Lunch break
1230	ANZCHOG ASM commences 1230 sharp with Acknowledgement of Country Dance and plenary session with Dr Arnold Paulino “Proton Therapy in Paediatric Cancer: What is the Evidence?”

Survivorship Workshop
WED 23 - THU 24 AUG

Both the Survivorship Workshops that are scheduled to take place on Wednesday 23 – Thursday 24 August have reached capacity. If you do wish to be added to a waitlist, please contact the ASM organisers via info@asm-anzchog.com

Wednesday 23 August 2023

Survivorship Workshop – Survivorship Day
1200-1700
Seminar Room 1, UWA, University Club, Entrance 1, Hackett Dr, Crawley WA 6009

Thursday 24 August 2023

Survivorship Workshop – Transition Day
0800-1100
Seminar Room 1, UWA, University Club, Entrance 1, Hackett Dr, Crawley WA 6009

Transport
For those requiring transport to the workshop/s (interstate attendees or those staying at The Westin), a chartered bus has been arranged to provide complimentary transportation to and from the workshops. The pickup and drop-off location will be at The Westin Perth. To reserve a spot on the bus, please email: wacog@cancerwa.asn.au

Nurses' Workshop
THU 24 AUG

When: Thursday 24 August
Where: Westin, Perth

	Program
0800-0815	Welcome ANZCHOG Board Chair Prof Nick Gottardo
0815-0830	EViQ Update Rachel Edwards
0830-0905	Relationships and Connection with Children Ranita Sidhu
0905-0945	Transplant-Associated Thrombotic Microangiopathy Maddie Gilsenan
0945-1015	Morning tea
1015-1045	Creating a strong research question Prof Natalie Bradford
1045-1115	Abstract Presentations Exploring health behaviours, self-efficacy and persistent symptoms in survivors of childhood cancer Natalie Bradford, Queensland University of Technology “Engage”: A survivorship program to improve young survivors’ health-related self-efficacy Dr Jordana McLoone, UNSW Sydney; Sydney Children’s Hospital Paediatric Oncology Workforce Survey: Addressing the Challenges and Opportunities Dr Karin, Plummer, Griffith University “Burn Out” – An opportunity for action and change Jayne Harrison, Children’s Cancer Centre, Royal Childrens Hospital
1115-1200	Workshop – Being at our Best. Managing the challenges of our chosen vocation Dr Julie Stone

Key for Program


Room TBC
0730-1130	ANZCHOG TACTIC (Transplantation & Cellular Therapy in Children) Group Annual Meeting (closed meeting)
Ballroom 1 & 2
1230-1300	Opening Ceremony and Acknowledgement of Country
1300-1400	Plenary 1 – Radiation Oncology Chairs – Tom Walwyn/Josh Dass Proton Therapy in Paediatric Cancer: What is the Evidence? Dr Arnold Paulino, University Of Texas MD Anderson Cancer Center, United States Speaker involvement made possible thanks to the support from SCGH RadOnc
1400-1500	Plenary 2 – Survivorship Chairs – Tom Walwyn/Josh Dass Future state of guidelines for survivors of paediatric /AYA cancer therapy: personalisation, evolving evidence and the survivorship clinician Dr Matthew Ehrhardt, St Jude Children’s Research Hospital, United States Speaker involvement made possible thanks to the support from
Ballroom 3
1500-1530	Afternoon tea – Trade Display and Poster Viewing
Ballroom 1 & 2
1530-1700	ANZCHOG Clinical Trials Update Chair – Annie Ryan/Santosh Valvi
1700-1800	ANZCHOG 2023 Best Abstract Presentations Chairs – Raelene Endersby/Siobhan Cross Australasian Methylation Array Profiling – Evolution beyond Accreditation Dr Christine White, Victorian Clinical Genetics Services A holistic approach to psychosocial support for parents and families of paediatric cancer patients in Aotearoa New Zealand: The National Child Cancer Counselling Network Assoc Prof Kirsty Ross, Massey University Development of Juvenile Models of Childhood Cancers Reveals Age-Specific Immune Signatures in Early Life Tumor Microenvironment Dr Omar Elaskalani, Telethon Kids Institute & University Of Western Australia MARVEL-PIC Minimising Adverse Drug Reactions and Verifying Economic Legitimacy – A Pre-emptive Pharmacogenomics Program in Paediatric Oncology Ms Claire Moore, Murdoch Children’s Research Institute Pulmonary complications in children following Haematopoietic stem cell transplant Dr Hannah Walker, The Royal Children’s Hospital Melbourne Neuroinflammation Drives Acute Lymphoblastic Leukaemia Therapy-Induced Adverse Effects Dr Hana Starobova, The University of Queensland
Ballroom 3
1800-2000	Welcome Reception

Key for Program


0730-0830	Ballroom 1	Ballroom 2
	Alexion Breakfast	0700-0830 Clinical Research Professionals Breakfast (Closed meeting)
	A new therapeutic option in NF1 PN Prof Jordan Hansford Brought to you by Alexion	Brought to you by Minderoo
Ballroom 1 & 2
0900-1000
0900-1000	Plenary 3 – Solid Tumour Chairs – Annie Ryan/Toby Trahair Current Challenges and Treatments for Relapsed Neuroblastoma Dr Lucas Moreno, Vall D’hebron Hospital, Spain Speaker involvement made possible thanks to the support from
Ballroom 3
1000-1030	Morning Tea – Trade Display and Poster Viewing
Ballroom 1 & 2
1030-1130	Plenary 4 – Leukaemia Chairs – Rishi Kotecha/Tina Carter Improving Global Childhood Cancer Outcomes through Advocacy, Policy, and Research Dr Sumit Gupta, The Hospital For Sick Children, Canada Speaker involvement made possible thanks to the support from
1130-1230	Plenary 5 – Haematology Chairs – Rishi Kotecha/Tina Carter Gene and targeted therapies in the Haemoglobinopathies – is a cure possible? Prof Joy Ho, Institute of Haematology, Royal Prince Alfred Hospital
Ballroom 3
1230-1330	Lunch – Trade Display and Poster Viewing
Eucalypt & Mallee Room
1240-1325	Jazz Pharmaceuticals – Lunch Symposium
1240-1325	Endothelial-related disorders following HSCT: focus on TA-TMA Introduction Dr Shanti Ramachandran, Perth Children’s Hospital Assoc Prof Adam Nelson, Sydney Children’s Hospital Endothelial-related disorders following HSCT: focus on transplant-associated thrombotic microangiopathy (TA-TMA) Prof Sonata Jodele, Cincinnati Children’s Hospital Medical Center, United States Q&A from audience Brought to you by Jazz Pharmaceuticals
1330-1500	Ballroom 1	Ballroom 2	Eucalypt & Mallee
1330-1500	Concurrent 1 – Solid/CNS Clinical Chairs – Marty Campbell/Enrica Tan Clinical Trial Development for Neuroblastoma Dr Lucas Moreno, Vall D’hebron Hospital, Spain Speaker involvement made possible thanks to the support from Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion cancer: an extended follow-up Dr Hetal Dholaria, Perth Children’s Hospital Prognostic Significance of Molecular Subgroups in the Survival Outcome for Children with Medulloblastoma in Malaysia Dr Revathi Rajagopal, Hospital Raja Permaisuri Bainun Making cancer therapy choices with a survivorship lens Dr Matthew Ehrhardt, St. Jude Children’s Research Hospital, United States Speaker involvement made possible thanks to the support from	Concurrent 2 – Leukaemia/Lymphoma Chairs – Diane Hanna/Sarah Trinder Standard Risk ALL: Time to declare victory, or change the paradigm Dr Sumit Gupta, The Hospital For Sick Children, Canada Speaker involvement made possible thanks to the support from Understanding the Morbidity and Mortality Associated With Cancer in Aboriginal and Torres Strait Islander Children Dr Jessica Buck, Telethon Kids Institute Incidence, cytogenetics and outcome in Polynesians with Pediatric Acute Myeloid Leukemia in New Zealand Dr Siobhan Cross, Waitaha Canterbury “It takes a village.” Improving childhood cancer survival in Papua New Guinea – A multi-disciplinary approach. Dr Sandra Staffieri, Royal Children’s Hospital/Centre for Eye Research Australia Stage-specific changes in incidence and survival for childhood cancers in Australia, 2000-2017 Assoc Prof Danny Youlden, Cancer Council Queensland	Concurrent 3 – Haematology Chairs – Lochie Teague/ Vanessa Verissimo New developments in Thalassemia management Prof Joy Ho, Institute of Haematology, Royal Prince Alfred Hospital Bleeding disorder of unknown cause (BDUC) – the most frequent mild bleeding tendency? Prof Ross Baker, Western Haematology and Oncology Clinics Survey outcome of immunisation route preference for persons with haemophilia in Australia Dr Tina Carter, Perth Children’s Hospital Chronic Thrombocytopenia at [Australasian Tertiary Paediatric Hospital]: Finding Molecular Clues Dr Yasheer Haripersad, Perth Children’s Hospital
Ballroom 3
1500-1530	Afternoon tea – Trade Display and Poster Viewing
1530-1600	Ballroom 1	Ballroom 2
	Recordati – Meet the Expert	Alexion – Meet the Expert
	Dinutuximab-Beta in High-Risk Neuroblastoma – experience and learnings at Vall d’Hebron Hospital, Barcelona Dr Lucas Moreno, Vall D’hebron Hospital, Spain Brought to you by Recordati Rare Diseases / EUSA Pharma	An Expert Panel Discussion: Lymphohistiocytosis (HLH) – The Importance in Identifying Treatable Genetic Conditions Dr Frank Alvaro, John Hunter Children’s Hospital Assoc Prof Kaustuv Bhattacharya, Sydney Children’s Hospitals’ Network Prof Maria Fuller Brought to you by Alexion
1600-1730	Ballroom 1	Ballroom 2	Eucalypt & Mallee
1600-1730	Concurrent 4 – Solid/CNS Chairs – Timothy Hassall/Neevika Manoharan For glioma: Towards cancer interception for gliomas in children adolescents and young adults Dr Uri Tabori, The Hospital for Sick Kids, Canada Clinical and preclinical considerations for the combination of radiotherapy, dordaviprone and paxalisib (NCT05009992) for the treatment of diffuse midline glioma Prof Matt Dun, The University Of Newcastle Australian Proton Therapy Experience Long-term Outcomes of Symptomatic Optic Pathway Glioma: 32-year Experience at a Single Western Australian Tertiary Paediatric Oncology Centre Dr Revathi Rajagopal, Hospital Raja Permaisuri Bainu Australian Proton Therapy Establishment Jordan Hansford, South Australian Health and Medical Research Institute	Concurrent 5 – Leukaemia/Lymphoma/Translational Chairs – Deborah White/Vincent Kuek Novel therapies in B-cell lymphoma with potential for translation to the paediatric/adolescent setting Prof Chan Cheah, Breakthrough Haematology Profiling Of Minimal Residual Disease Opens Novel Avenues For Treatment In Down Syndrome Acute Lymphoblastic Leukaemia Dr Sebastien Malinge, Telethon Kids Institute – Cancer Centre High expression of DUX4 mRNA is a reliable indicator of DUX4-rearranged acute lymphoblastic leukaemia Ms Jacqueline Rehn, South Australian Health And Medical Research Institute Targeting Osteoclasts for Treatment of High-risk B-cell Acute Lymphoblastic Leukaemia Dr Laurence Cheung, Telethon Kids Institute and Curtin University Evaluation of an Enhanced Influenza Vaccination schedule in Immunocompromised Children undergoing Cancer Treatment Dr Sung Kai Chiu, Telethon Kids Institute	Concurrent 6 – Haematology Chairs – Carly George/ Joy Ho Update on thrombosis management in children Prof Paul Monagle, Royal Children’s Hospital Exciting new developments in the world of vascular malformations Dr Sue Russell, Kids Cancer Centre ANZ Platelet Group Update Dr Tina Carter, Perth’s Children Hospital
Ballroom 3
1730-1900	Poster session One Hundred Times Better, at Home in Our Own Beds: Implementation of Home Intravenous Hydration After Chemotherapy in Children with Cancer Rebekah Orford, Oncology Cytokines in Radioresistant Paediatric Craniopharyngiomas Enrica EK Tan, KK Women’s and Children’s Hospital Changing Trend of Transplant Donor for Primary Immunodeficiency Disorders and Outcome in Single Institution Mya Soe Nwe, KK Women’s and Children’s Hospital Role of glia maturation factor beta (GMFβ), an actin depolymerising factor, in neuroblastoma differentiation David Eisenstat, The Royal Children’s Hospital Melbourne Bioluminescence Platform to Identify Stroma-mediated Chemoresistance in Leukaemia Rhiannon Panting, Telethon Kids Institute

Key for Program


Boardroom 1
0700-0830	ANZCHOG Psycho-Oncology Group Meeting (Closed Meeting)
Eucalypt & Mallee
0700-0830	Nurse Professional Breakfast (Closed Meeting)
Ballroom 1 & 2
0830-0930	Plenary 6 – Transplant & Cellular Therapy Chairs – Melissa Gabriel/Tim Prestidge Transplant-Associated Thrombotic Microangiopathy: Consensus Definitions and Up-to-Date Management Prof Sonata Jodele, Cincinnati Children’s Hospital Medical Center, United States Speaker involvement made possible thanks to the support from
Ballroom 3
0930-1000	Morning Tea – Trade Display and Poster Viewing
Ballroom 1 & 2
1000-1100	Plenary 7 – Solid/CNS Tumours Chairs – Gordon Miles/Jordan Hansford Histone mutations in disease: tell a tale of a histone Dr Nada Jabado, McGill University, Canada Speaker involvement made possible thanks to the support from
1100-1200	Plenary 8 – Psychosocial Chairs – Gordon Miles/Jordan Hansford Maintaining our capacity to think: Facing and embracing the challenges and distress inherent in our work with children and families. Dr Julie Stone, Child & Family Psychiatrist Ranita Sidhu, Perth Children’s Hospital Speaker involvement made possible thanks to the support from
Ballroom 3
1200-1300	Lunch – Trade Display and Poster Viewing
Eucalypt & Mallee
1210-1255	Bayer – Lunch Symposium
1210-1255	Pathways to Precision: Accelerating Funded Access to Genomic Testing Assoc Prof Antoinette Anazodo Dr. Vivek Rathi Brought to you by Bayer
1300-1515	Ballroom 1	Ballroom 2	Eucalypt & Mallee
1300-1515	Concurrent 7 – Solid/CNS Preclinical Chairs – Matt Dun/ Dinisha Govender For replication repair deficiency: Updates and new concepts for patients with replication repair deficient cancers. Dr Uri Tabori, The Hospital for Sick Kids, Canada Improving survival in high-risk Group 3 and SHH-3 models of medulloblastoma with use of radiosensitising effect of inhibitors of DNA damage response pathway. Dr Hetal Dholaria, Perth Children’s Hospital Targeting the Anti-apoptotic Protein BCL2 with Venetoclax Combination Treatment in High-risk Neuroblastoma Dr Alvin Kamili, Children’s Cancer Institute Inhibiting cell cycle checkpoints improves the efficacy of chemotherapy in pineoblastoma. Dr Meegan Howlett, Telethon Kids Institute Surgery is a window of opportunity: biomaterial-assisted delivery of immunotherapy reduces local recurrence of soft tissue sarcoma Dr Ben Wylie, Telethon Kids Institute HER2-Chimeric Antigen Receptor T cells show Preclinical Efficacy in Intracranial DMG Models Dr Alexander Davenport, Walter and Eliza Hall Institute Targeting Oncohistones in Cancer Dr Nada Jabado, McGill University, Canada Speaker involvement made possible thanks to the support from	Concurrent 8 – Psychosocial/Survivorship/Allied Health Chairs -Geoff McCowage /Jemma Langer Mental health problems in children with cancer: putting the evidence into context Prof David Coghill, The Royal Children’s Hospital, Melbourne Speaker involvement made possible thanks to the support from Fatigue in Children following Treatment for Acute Lymphoblastic Leukaemia: A Longitudinal Study Dr Cinzia De Luca, The Royal Children’s Hospital Melbourne “Burn Out” – An opportunity for action and change Ms Jayne Harrison, Children’s Cancer Centre, Royal Childrens Hospital Financial toxicity of paediatric cancer in Australia: A real-time assessment of the financial support needs of families during the cost-of-living crisis Dr Eden Robertson, Redkite Devising a tailored model of care to support procedural distress in paediatric oncology patients Miss Emma Kerr, Queensland Children’s Hospital Quality of Life, Family Functioning and the needs for Psyhcosical support After Paediatric Brain Tumour Diagnosis Prof Natalie Bradford, Queensland University of Technology Effect of an online nutrition intervention (Reboot-Kids) on the dietary intake of young childhood cancer survivor’s fruit and vegetable intake: A randomised-controlled trial Dr Amy Lovell, The University of Auckland Longitudinal Trajectories of Parents’ Psychological Wellbeing Following Their Child’s Treatment for Acute Lymphoblastic Leukaemia Dr Michelle Tennant, Murdoch Children’s Research Institute Predictors of Communication Difficulties in Children Treated for Brain Tumour: An Observational Study Ms Toni Bird, Sydney Children’s Hospital Network Do young people who survive cancer, identify as ‘survivors’? Prevalence and predictors of cancer-related identities among adolescents and young adults following cancer Dr Ursula Sansom-Daly, UNSW Sydney When, and how, should we talk about palliative care concepts with adolescents and young adults with cancer? Results from an international Delphi study. Dr Ursula Sansom-Daly, UNSW Sydney	Concurrent 9 – Transplant & Cellular Therapy Chairs – Richard Mitchell/Michelle Ng Navigating Endothelial Injury Maze in Transplant-Associated Thrombotic Microangiopathy Prof Sonata Jodele, Cincinnati Children’s Hospital Medical Center, United States Speaker involvement made possible thanks to the support from Myeloablative Busulfan, Fludarabine and Melphalan Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation in Childhood Myeloid Malignancy Dr Mayank Dhamija, Bristol Royal Hospital For Children Precision gene editing for Fanconi Anemia Dr Lorna Mcleman, Royal Children’s Hospital and St Vincent’s Institute of Medical Research CAR-T Cell Therapy Dr Seong Lin Khaw, Royal Children’s Hospital A retrospective audit of medical and allied health service usage by patients treated in the first year of the Royal Children’s Hospital CAR-T program Dr Maria Mccarthy, Murdoch Children’s Research Institute Expert Panel Discussion: To be or not to be, that is the question…. Cell therapy in Neuroblastoma Dr Chris Fraser, Queensland Children’s Hospital Prof Sonata Jodele, Cincinnati Children’s Hospital Medical Center Dr Seong Lin Khaw,The Royal Children’s Hospital Melbourne
Ballroom 3
1515-1545	Afternoon tea – Trade Display and Poster Viewing
Ballroom 1 & 2
1545-1700	When the going gets tough, the tough get…… Chair – Angela Alessandri Panel Discussion Dr Julie Stone, Child & Family Psychiatrist Ranita Sidhu, Perth Children’s Hospital Dr Angela Alessandri, Perth Children’s Hospital Liz Darch, Perth Children’s Hospital Dr Julie Stone and Dr Angela Alessandri involvement made possible thanks to the support from
1700-1715	Closing ceremony
1900-2400	Gala Dinner

A/Prof Sumit Gupta

Hospital For Sick Children

Dr Angela Alessandri

Perth Children's Hospital

Dr Arnold Paulino

University Of Texas Md Anderson Cancer Center

Dr Julie Stone

Child & Family Psychiatrist

Dr Lucas Moreno Martin Retortillo

Vall D'hebron Hospital

Dr Matthew Ehrhardt

St. Jude Children's Research Hospital

Dr Nada Jabado

McGill University

Dr Phoebe Joy Ho

Institute of Haematology, Royal Prince Alfred Hospital, Head of Department

Dr Seong Lin Khaw

Royal Children's Hospital

Dr Susan Russell

Sydney Children's Hospital

Dr Uri Tabori

The Hospital For Sick Children

Prof Chan Cheah

Sir Charles Gairdner Hospital

Prof Paul Monagle

Professor Paediatrics, University Of Melbourne

Prof Sonata Jodele

Cincinnati Children's Hospital Medical Center

Ranita Sidhu

Perth Children’s Hospital

2022 Annual Scientific Meeting

Partners
Program
Speakers

Silver Partner, Exhibitor

Diamond Partner, Exhibitor

Silver Partner, Exhibitor

Silver Partner

Conference App Partner

App Partner

Keynote Speaker Partner

Exhibitor

Pre-ASM 27/07/2022
Thurs 28/07/2022
Fri 29/07/2022
Sat 30/07/2022
Partner Program

The pre-ASM nursing workshop is included with the Full ASM Delegate registration type. Space for this workshop is limited and you will need to indicate during the registration process if you would like to attend.

Venue: Hyde Park Room, Sheraton Grand Hyde Park, Sydney
0900-1700	ANZCHOG Nurses Pre Conference Workshop Program
	Chair: Chrissy Hanmore
0900-0905	Welcome & housekeeping
0905-0950	The importance of self-care and the impact of the pandemic Dr Justin Baker St Jude Children’s Research Hospital
0950-1035	Hiding in plain sight. Nursing’s superpower Prof Mei Krishnasamy Peter MacCallum Cancer Centre
1035-1055	Morning tea
1055-1120	Genomics and targeted therapy in childhood cancer Dr Loretta Lau Kids Cancer Centre SCH
1120-1145	Haemophilia overview and what’s the treatment plan for 2022 Grainne Dunne Sydney Children’s Hospital
1145-1210	Fertility and emerging therapies Tejnei Vaishnav Royal Hospital for Women, NSW
1210-1230	The role and value of the research nurse A/Prof Natalie Bradford Queensland University of Technology
1230-1300	Lunch
1300-1430	What’s on your eLearning wishlist? eviQ Education showcase and workshop
1430-1450	The Druggle, Improving Paediatric Oncology Drug Knowledge in Real Time Ms Genevieve Daly Kids Cancer Centre, Sydney Children’s Hospital
1450-1505	Afternoon tea
1505-1535	Navigating end-of-life conversations with adolescents and young adults using the Australian Voicing My Choices tool: best practice & case examples Dr Ursula Samson-Daly, Cath O’Dwyer & Fiona Maguire Sydney Children’s Hospital
1535-1605	Children and Adolescents with Cancer: Neuropsychological effects, education needs and interventions Dr Soheil Afshar Sydney Children’s Hospital
1605-1635	Health and wellbeing after cancer: a multidisciplinary program for long-term survivors of childhood malignancies Dr Christina Signorelli, Karen Johnston & Rachael Bell Sydney Children’s Hospital Presented by Dr Jordana McLoone & Rachael Bell
1635-1700	ANZCHOG Nurses Update, Evaluations and Close

Brought to you by

You will have the option to register your attendance to the Parent Program during the registration process for the ASM.

If you would like to attend the virtual Parent Program only please proceed via the standard registration portal and use registration code*: PAR22 when prompted in order to bypass the ASM registration.

^{*Please note, by using this code, you will not be registered to attend the ASM or any of the social functions.}

Example


0930-1510 AEST	Parent Program
	Chair: Donna Drew
0930-0935	Welcome and house keeping for virtual attendees
0935-0955	Keeping up with school during and after childhood cancer Joanna Fardell
0955-1015	Managing social challenges during and after childhood cancer Clarissa Schilstra
1015-1030	Questions
1030-1045	Morning tea
1045-1115	When your child has cancer, goals of care, hope and compassion Justin Baker
1115-1145	Minimising the psychological impact of cancer treatment on children and adolescents Liane Willis
1145-1215	Questions
1215-1300	Lunch 1240-1300: Lunch session: “Would a national voice from parents lead to improved cancer support for families?” AND “What steps could be taken to build that voice?” A discussion led by Tim Rogers from Redkite
	Chair: Joanna Fardell
1300-1320	Staying fit and active during and after cancer Lauren Ha
1320-1340	Managing the needs of siblings who have a brother or sister with cancer Brittany McGill
1350-1400	Afternoon tea
1400-1420	When and how do I talk to my child about their cancer experience : side effects, experience, fertility Tali Foreman
1420-1440	Survivor’s Story: Clarissa will share her story about her cancer diagnosis, relapse, survivorship, academic achievements and being a mum Clarissa
1500-1510	Summary of the day & close

The Parent Day program is scheduled in AEST.

Brought to you by


0900-0915	Opening ceremony
0915-1015	Plenary 1
	Location: Grand Ballroom
	Chair: Dr Richard Mitchell Improving patient outcomes through integrated paediatric palliative care Dr Justin Baker St Jude Children’s Research Hospital ^{The ASM would like to acknowledge The Kids’ Cancer Project for the support of Dr Justin Baker’s attendance as an invited speaker.}
1015-1045	Morning tea – Trade display and poster viewing
1045-1130	Plenary 2
	Location: Grand Ballroom
	Chair: Dr Richard Mitchell Old drugs and new: Still so much to learn about haemostasis in children Prof Paul Monagle Kids Cancer Centre, Sydney Children’s Hospital/University of Melbourne
1130-1215	Plenary 3
	Location: Grand Ballroom
	Chair: Dr Richard Mitchell Fertility preservation in young people: The new standard of care Dr Yasmin Jayasinghe Royal Children’s Hospital Melbourne
1215-1315	Lunch – Trade display and poster viewing
1245-1315	Partner lunch symposium 1 Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT
	Location: Hyde Park Room
	Prof Selim Corbacioglu Children’s Hospital Regensburg Germany Brought to you by
1315-1445	Concurrent 1: Non malignant haematology	Concurrent 2: Translational Medicine	Concurrent 3: Patient experience
	Location: Ballroom 1	Location: Ballroom 2	Location: Hyde Park Room
	Chair: Prof Paul Monagle Current management of sickle cell disease Dr Anthea Greenway Royal Children’s Hospital Melbourne Iron deficiency anaemia Prof Sant-Rayn Parischa Walter and Eliza Hall Institute of Medical Research Transfusion medicine Dr Gemma Crighton Royal Children’s Hospital Melbourne	Chair: Dr Noemi Fuentes Bolanos Computational Biology in Oncology Drug Discovery A/Prof Antoine de Weck Children’s Cancer Institute A Comprehensive Patient-Derived Xenograft Model Platform to Support Translational Neuroblastoma Research Dr Jamie Fletcher Children’s Cancer Institute A novel paediatric oncology mouse clinic Ms Zahra Abbas Telethon Kids Institute Targeting the Anti-apoptotic Protein BCL2 With Venetoclax Combination Treatment in High-risk Neuroblastoma Ms Madeleine Wheatley Children’s Cancer Institute Exploiting Arginine Addiction to Treat High-Risk Neuroblastoma Dr Kimberley Hanssen Children’s Cancer Institute	Chair: Donna Drew Hoping against hope – Supporting hope in advancing illness Dr Justin Baker St Jude Children’s Hospital Memphis ^{The ASM would like to acknowledge The Kids’ Cancer Project for the support of Dr Justin Baker’s attendance as an invited speaker.} ASSET: Collecting patient toxicity data and quality of life data together, where to next? Dr Joanna Fardell Kids Cancer Centre, Sydney Children’s Hospital Do long term survivors adhere to recommendations provided by MDT review? Dr Jordana McLoone Kids Cancer Centre, Sydney Children’s Hospital Developing a model of care for AYA patients with culturally diverse backgrounds Dr Azhani Amiruddin Crown Princess Mary Cancer Centre
1445-1515	Afternoon tea – Trade display and poster viewing
1515-1700	Concurrent 4: Non malignant haematology	Concurrent 5: Solid tumours	Concurrent 6: Patient experience
	Location: Ballroom 1	Location: Ballroom 2	Location: Hyde Park Room
	Chair: Prof Paul Monagle Novel treatments of ITP Dr Sally Campbell Royal Brisbane & Women’s Hospital Current care in haemophilia Janine Furmedge Royal Children’s Hospital Melbourne National guidelines for ITP Dr Tina Carter & Dr Vanessa Verissimo Perth Children’s Hospital	Chair: Dr Felicity Wright Current therapies in neuroblastoma Dr Toby Trahair Kids Cancer Centre, Sydney Children’s Hospital Recruitment principles and strategies for supportive care research in paediatric oncology A/ Prof Natalie Bradford Queensland University of Technology The outcome of paediatric extracranial malignant germ cell tumours: ten years experience of a single institution in Southern Vietnam Dr T. T. An Dao University of Medicine and Pharmacy At Ho Chi Minh City The NCI/COG Molecular Characterisation Project and Zero2 – an update Prof Nick Gottardo Perth Children’s Hospital A/Prof Vanessa Tyrrell Children’s Cancer Institute	Chair: Chrissy Hanmore Health workers’ understanding of and barriers to palliative care services for Aboriginal children with cancer Dr Sophie Jessop Kids Cancer Centre SCH “Torn in Two” Experiences of mothers who are pregnant when their child is diagnosed with cancer Ms Jenny Davies Curtin University Identifying education and employment outcomes and support needs in Adolescents and Young Adults diagnosed with cancer Dr Jennifer Cohen Canteen, Australia Fathers’ Experiences of Childhood Cancer Ms Jenny Davies Curtin University Home-Based Hydration for Chemotherapy – Its Clinical Impact and the Experience of Paediatric Oncology Patients and Their Families Mrs Jennifer Arguelles Paediatric Integrated Cancer Service The management of pain for children hospitalised during Haematopoietic Stem Cell Transplantation Dr Karin Plummer Griffith University
1700-1900	Welcome reception


0730-0830	Partner breakfast 1 CAR-T for ALL IN 2022	Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology
	Location: Ballroom 1	Location: Hyde Park Room
	SeongLin Khaw Royal Children’s Hospital, Melbourne Brought to you by	Chair: Professor Nick Gottardo Perth Children’s Hospital Dr Brendan McMullan Sydney Children’s Hospital Dr Daniel Yeoh Perth Children’s Hospital Brought to you by
0900-1000	Plenary 4
	Location: Grand Ballroom
	Chair: Prof Claire Wakefield You should ask that: The different faces of life after treatment Dr Robert Battisti Children’s Hospital Westmead
1000-1030	Morning tea – Trade display and poster viewing
1030-1130	ANZCHOG 2022 Best abstracts
	Location: Grand Ballroom
	Chair: Dr Richard Mitchell Molecular monitoring of ctDNA in neuroblastoma patients for response monitoring and relapse prediction Dr Vinod Vijay Subhash Children’s Cancer Institute Cardio-oncology guidelines for paediatric oncology patients: A Delphi consensus approach to inform risk stratification, surveillance and management during active cancer therapy. Mr Ben Felmingham Murdoch Children’s Research Institute Generation and Multi-Dimensional Profiling of a Childhood Cancer Cell Line Atlas Defines New Therapeutic Opportunities Dr Paul Daniel Hudson Institute Of Medical Research
1130-1200	ANZCHOG foundations lecture
	Location: Grand Ballroom
	Chair: Prof Les White A history of paediatric stem cell transplantation in Australia Prof Marcus Vowels
1200-1300	Lunch – Trade display and poster viewing
1225-1255	Partner lunch symposium 2 Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer
	Location: Hyde Park Room
	Professor David Ziegler Kids Cancer Centre MD Theodore W. Laetsch Children’s Hospital of Philadelphia/University of Pennsylvania Brought to you by
1300-1430	Concurrent 7: Neuro-oncology	Concurrent 8: Precision medicine	Concurrent 9: Global oncology in Oceania: A joint SIOP-ANZCHOG symposium across disciplines
	Location: Ballroom 2	Location: Ballroom 1	Location: Hyde Park Room
	Chair: Dr Neevika Manoharan Holistic care for paediatric brain tumours: 2022 and beyond A/Prof Jordan Hansford Women’s and Children’s Hospital Adelaide ^{The ASM would like to acknowledge the Robert Connor Dawes Foundation for the support of A/Prof Jordan Hansford’s attendance as an invited speaker.} Epigenetic regulation of innate signaling in brain tumours: Implications for novel therapeutic approaches. Dr David M. Ashley Duke University Preliminary Analysis of the Pharmaco-phospho-proteo-genomic Landscape of Paediatric High-grade Gliomas Mr Izac Findlay University Of Newcastle Determining the Clinical Utility of the Immune Modulating Antibody Anti-CD47 in a Preclinical Model of Medulloblastoma. Dr Meegan Howlett Telethon Kids Institute The development of ACT001 as a novel combination therapeutic for diffuse intrinsic pontine gliomas Dr Dannielle Upton Children’s Cancer Institute	Chair: Dr Karen McCleary Precision Medicine 101 Dr Loretta Lau Kids Cancer Centre SCH High-Throughput Drug Testing on Patient-Derived Models Identifies Novel Rational Treatment Options for Paediatric Cancer Patients Dr Emmy Dolman Children’s Cancer Institute Precision medicine is changing the roles of healthcare professionals, scientists, and research staff: Learnings from a childhood cancer precision medicine trial. Ms Rebecca Daly UNSW	Chairs: Professor Claire Wakefield & Dr Michael Sullivan Improving child cancer care in Oceania, working with the World Health Organisation, and welcome remarks from global leaders Professor Claire Wakefield Continental President of SIOP Oceania Working together to support regional development of child cancer care: The ARIA Global Guideline Collaboration Professor Michael Sullivan (Chair SIOP Global Health) Supporting nursing education in Oceania: What’s going on in our neighbourhood? Ms Jayne Harrison A showcase of child cancer care strengths and challenges in our region, featuring clinicians from Papua New Guinea, Fiji, New Caledonia, Tonga and Timor Leste Dr Gwenda Anga, Papua New Guinea; Dr Miri Thaggard, Fiji; Dr Gregory Harvet, New Caledonia; Dr Meleane Toafa, Tonga, Dr Milena Santos, Timor Leste Discussion and Q&A
1430-1500	Afternoon tea – Trade display and poster viewing
1500-1630	Concurrent 10: Neuro-oncology	Concurrent 11: Leukaemia/Cellular Therapy	Concurrent 12: ANZCHOG Trial & Research updates
	Location: Ballroom 2	Location: Ballroom 1	Location: Hyde Park Room
	Chair: Prof Richard Cohn Long-term control and safety of larotrectinib in a cohort of adult and paediatric patients with tropomyosin receptor kinase (TRK) fusion primary central nervous system (CNS) tumours A/ Prof Jordan Hansford Women’s and Children’s Hospital Adelaide Australasian Methylation Array Profiling – an Update on the AIM BRAIN PROject Dr Christine White Victorian Clinical Genetics Services Characteristics of Children with Brain Cancer: A 10-Year Retrospective Cohort A/ Prof Natalie Bradford Queensland University of Technology Preclinical optimisation of the PI3K/AKT/mTOR inhibitor paxalisib for the treatment of diffuse intrinsic pontine glioma Dr Ryan Duchatel University Of Newcastle	Chair: Dr Adam Nelson CAR-T cells for B-ALL: Real world data and beyond MD Theodore W. Laetsch Children’s Hospital of Philadelphia/University of Pennsylvania Cooperative deletions of key lymphoid transcription factors strongly associated with recurrent genomic lesions in B-cell acute lymphoblastic leukaemia Ms Jacqueline Rehn South Australian Health and Medical Research Institute Vincristine-Induced Peripheral Neuropathy: Assessing Preventable Strategies in Paediatric Acute Lymphoblastic Leukemia. Dr Benjamin Schreiber Children’s Cancer Institute Reinventing The Wheel – Changing High Dose Methotrexate Habits Dr Phoebe Power Sydney Children’s Hospital Chimeric Antigen Receptor (CAR) T cell Therapy: Updated Outcomes at a Single Centre Dr Seong Lin Khaw Royal Children’s Hospital Melbourne	Chair: Dr Maria Kirby 1500-1515: Registries, biobanking and supportive care research 1515-1545: Leukaemia/lymphoma and solid tumours clinical trials 1545-1625: CNS clinical trials and ZERO2 initiatives 1625-1630: Trial governance updates
1630-1700	Meet the experts 1 Clinical use of asparaginase	Meet the expert 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma
	Location: Ballroom 1	Location: Ballroom 2
	Dr Siobhan Cross Canterbury District Health Board Jessica Nicholson Children’s Health Queensland Brought to you by	Dr Martin Campbell Royal Children’s Hospital Melbourne Dr Aleksandra Wieczorek University Children’s Hospital, Krakow Brought to you by
1900-2300	Gala dinner The Eveleigh, Bay 3, 2 Locomotive St, Eveleigh NSW 2015


0900-1100	Panel discussion
	Location: Grand Ballroom
	Moderator: Annabel Crabb ABC journalist Ava’s Journey – Decision making in the age of early phase trials Panelists: Prof David Ziegler, Kids Cancer Centre, Sydney Children’s Hospital; Dr Justin Baker, St. Jude Children’s Research Hospital; Prof Mary Chiarella, University of Sydney; Ben Charlton Maryanne Larkin
1100-1130	Morning tea – Trade display and poster viewing
1130-1230	Plenary 5
	Location: Grand Ballroom
	Chair: Dr Richard Mitchell Communication as a Cornerstone of Care: What We Say and How We Say It Matters Dr Justin Baker St Jude Children’s Hospital Memphis ^{The ASM would like to acknowledge The Kids’ Cancer Project for the support of Dr Justin Baker’s attendance as an invited speaker.}
1230-1300	Closing ceremony
	Location: Grand Ballroom
	Chair: Dr Richard Mitchell Best abstract awards Thanks for attending ASM 2022 Join us for ASM 2023

Day 1 - Thursday 28 July
1245 – 1315	Partner Lunch Symposium Transplant related Endotheliopathy: Status Quo of the most significant complications in HSCT
	Prof Selim Corbacioglu Children’s Hospital Regensburg Germany Brought to you by

Day 2 - Friday 29 July
0730 – 0830	Partner breakfast 1 CAR-T for ALL IN 2022	Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology
	SeongLin Khaw Royal Children’s Hospital, Melbourne Brought to you by	Chair: Professor Nick Gottardo Perth Children’s Hospital Dr Brendan McMullan Sydney Children’s Hospital Dr Daniel Yeoh Perth Children’s Hospital Brought to you by
1225 – 1255	Partner Lunch Symposium 2 Efficacy and safety of larotrectinib in paediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer
	Professor David Ziegler Kids Cancer Centre MD Theodore W. Laetsch Children’s Hospital of Philadelphia/University of Pennsylvania Brought to you by
1630 – 1700	Meet the experts 1 Clinical use of asparaginase	Meet the experts 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma
	Dr Siobhan Cross Canterbury District Health Board Jessica Nicholson Children’s Health Queensland Brought to you by	Dr Martin Campbell Royal Children’s Hospital Melbourne Dr Aleksandra Wieczorek University Children’s Hospital, Krakow Brought to you by

Day 2 - Friday 29 July
0730 – 0830	Partner breakfast 1	Partner breakfast 2 Translating guidelines to practice – focus on COVID and IFIs in paediatric haematology and oncology
	Brought to you by	Professor Nick Gottardo Perth Children’s Hospital, Australia Dr Brendan McMullan Sydney Children’s Hospital, Australia Dr Daniel Yeoh Perth Children’s Hospital, Australia Brought to you by
1230 – 1300	Partner Lunch Symposium 2 Efficacy and safety of larotrectinib in pediatric patients with tropomyosin receptor kinase (TRK) fusion-positive cancer
	Professor David Ziegler Kids Cancer Centre MD Theodore W. Laetsch Children’s Hospital of Philadelphia/University of Pennsylvania Brought to you by
1630 – 1700	Meet the experts 1 Clinical use of asparaginase	Meet the experts 2 Dinutuximab beta as immunotherapy in high-risk neuroblastoma
	Dr Siobhan Cross Canterbury District Health Board Jessica Nicholson Children’s Health Queensland Brought to you by	Dr Martin Campbell Royal Children’s Hospital Melbourne Dr Aleksandra Wieczorek University Children’s Hospital, Krakow Brought to you by

A/Prof Yasmin Jayasinghe

Other Invited Speakers

Dr Tina Carter

Perth Children’s Hospital

Janine Furmedge

Royal Children’s Hospital Melbourne

Dr Anthea Greenway

Royal Children’s Hospital Melbourne

Dr Jordana McLoone

Kids Cancer Centre, Sydney Children’s Hospital

Prof Sant-Rayn Parischa

Walter and Eliza Hall Institute of Medical Research

Cookie	Duration	Description
.ASPXANONYMOUS	12 hours	This cookies is set by ASP.NET and is used to track users within a session without requiring the user to log in.
ARRAffinity	session	ARRAffinity cookie is set by Azure app service, and allows the service to choose the right instance established by a user to deliver subsequent requests made by that user.
ARRAffinitySameSite	session	This cookie is set by Windows Azure cloud, and is used for load balancing to make sure the visitor page requests are routed to the same server in any browsing session.
cookielawinfo-checkbox-advertisement	session	Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
CookieLawInfoConsent	session	Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	2 years	The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
_ga_CXDS3XEJ90	2 years	This cookie is installed by Google Analytics.
_gat_gtag_UA_188778553_3	1 minute	Set by Google to distinguish users.
_gid	1 day	Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.

2024 Annual Scientific Meeting

2023 Annual Scientific Meeting

2022 Annual Scientific Meeting

Other Invited Speakers

About

Organiser

About

Program

Partners

Organiser